Recent study supports expanded access to HPV testing through self-sampling

In 2019, greater than 12,000 latest cases of cervical cancer were diagnosed in america and over 4,000 patients died. The causal relationship between human papillomavirus (HPV) infection and the event of cervical cancer is well documented. Cervical cancer screening guidelines are currently being reviewed for updates. On May 15, 2024, the U.S. Food and Drug Administration (FDA) approved patient-administered testing (vaginal self-sampling) for HPV. Several countries, including the Netherlands and Australia, have introduced HPV self-sampling as a part of their national screening programs.

In a brand new study from Boston University’s Chobanian & Avedisian School of Medicine and the University of Hawaii at Manoa School of Nursing, researchers found that greater than half of healthcare providers would definitely or possibly offer HPV self-sampling to their patients if the FDA approved the procedure, indicating significant adoption of this technology inside healthcare providers.

Healthcare providers believed that self-sampling could be particularly helpful for patients who wouldn’t have access to physician screening tests, in addition to for patients who can have difficulty with pelvic exams for any reason, corresponding to patients with a history of trauma, patients who’re sexual or gender minorities, and people with mobility issues.”

Rebecca B. Perkins, Professor of Obstetrics and Gynecology, Boston University School of Medicine

This study employed a mixed methods design that included conducting a national survey and interviews with healthcare providers who perform cervical cancer screening. Quantitative measures consisted of provider/practice characteristics, willingness to recommend, and preferences regarding self-sampling. Interviews further clarified provider perspectives.

The study found that male physicians, advanced practice specialists, internists, and general practitioners, in addition to physicians practicing in an educational medical center, hospital, or community hospital, were more prone to support self-collection than female participants, gynecologists, and physicians in private practice.

“We found that providers viewed HPV self-sampling as a strategy to expand patient access, but additionally they expressed concerns concerning the quality of the sample in generating accurate results,” added Holly Fontenot, PhD, RN/NP, FAAN. Professor of nursing on the University of Hawaii and lead writer of the study.

In line with the researchers, the recent approval of HPV self-sampling in america provides an alternative choice for cervical cancer screening which will help reduce barriers related to access or personal medical conditions.